$463.43
-0.57-0.12%
À la fermeture: -
$461.00
-2.43-0.52%
Après les heures de négociation: Oct 24, 4:16 PM EDT
Comments
Loading...
Orientation et prévision
Alnylam Pharmaceuticals publie des prévisions sur le BPA et les revenus futurs, donnant aux investisseurs un aperçu du montant que la société s'attend à gagner au cours des prochaines périodes.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
07/31/2025 | ALNY | Alnylam Pharmaceuticals | FY | 2025 | — | — | — | $3.30B | $3.55B | $3.01B | |
05/01/2025 | ALNY | Alnylam Pharmaceuticals | FY | 2025 | — | — | — | $2.70B | $3.00B | $2.89B | |
02/13/2025 | ALNY | Alnylam Pharmaceuticals | FY | 2025 | — | — | — | $2.70B | $3.00B | $2.68B | |
10/31/2024 | ALNY | Alnylam Pharmaceuticals | FY | 2024 | — | — | — | $2.15B | $2.30B | $2.23B | |
08/01/2024 | ALNY | Alnylam Pharmaceuticals | FY | 2024 | — | — | — | $2.15B | $2.30B | $1.88B | |
05/02/2024 | ALNY | Alnylam Pharmaceuticals | FY | 2024 | — | — | — | $1.73B | $1.93B | $1.85B | |
02/15/2024 | ALNY | Alnylam Pharmaceuticals | FY | 2024 | — | — | — | $1.73B | $1.93B | $1.78B | |
11/02/2023 | ALNY | Alnylam Pharmaceuticals | FY | 2023 | — | — | — | $1.77B | $1.91B | $1.44B | |
08/03/2023 | ALNY | Alnylam Pharmaceuticals | FY | 2023 | — | — | — | $1.30B | $1.46B | $1.44B | |
05/04/2023 | ALNY | Alnylam Pharmaceuticals | FY | 2023 | — | — | — | $1.30B | $1.46B | $1.39B | |
02/23/2023 | ALNY | Alnylam Pharmaceuticals | FY | 2023 | — | — | — | $1.30B | $1.46B | $1.48B | |
10/27/2022 | ALNY | Alnylam Pharmaceuticals | FY | 2022 | — | — | — | $970.00M | $1.08B | $1.07B | |
07/28/2022 | ALNY | Alnylam Pharmaceuticals | FY | 2022 | — | — | — | $970.00M | $1.08B | $1.09B | |
04/28/2022 | ALNY | Alnylam Pharmaceuticals | FY | 2022 | — | — | — | $870.00M | $930.00M | $1.17B | |
10/28/2021 | ALNY | Alnylam Pharmaceuticals | FY | 2021 | — | — | — | $790.00M | $865.00M | $853.11M | |
08/03/2021 | ALNY | Alnylam Pharmaceuticals | FY | 2021 | — | — | — | $790.00M | $865.00M | $837.45M | |
04/29/2021 | ALNY | Alnylam Pharmaceuticals | FY | 2021 | — | — | — | $760.00M | $860.00M | $824.74M | |
02/11/2021 | ALNY | Alnylam Pharmaceuticals | FY | 2021 | — | — | — | $760.00M | $860.00M | $796.86M |
FAQ
Quelles sont les dernières directives pour Alnylam Pharmaceuticals (ALNY) ?
Il n'y a eu aucune orientation spécifique sur les ventes ou les bénéfices rapportée pour Alnylam Pharmaceuticals ces derniers mois.
Parcourir guidance et prévisions sur toutes les actions.